LoadingLoadingLoading30 funds hold it.Insiders net selling.
Net selling: insiders sold $198.9M and bought $0 on the open market in 90 days (SEC Form 4). Congress: net buying of $3K to $45K in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Oct 21, 2026
Period ending
Sep 30, 2026
Earnings per share
$4.46 expected
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Oct 21, 2026 | $4.84est. $4.46 | +8.49%beat | $716.0MSEC filing | +8.5%from $659.9M |
| Jun 30, 2026Reported Jul 22, 2026 | $4.25est. $4.00 | +6.15%beat | $707.3MSEC filing | +17.2%from $603.3M |
| Mar 31, 2026Reported Apr 22, 2026 | $4.28est. $3.96 | +8.20%beat | $706.6MSEC filing | +26.5%from $558.6M |
| Dec 31, 2025Reported Feb 9, 2026 | $4.67est. $4.23 | +10.50%beat | $708.5MAlpha Vantage | +32.0%from $536.6M |
| Sep 30, 2025Reported Oct 22, 2025 | $3.86est. $3.57 | +8.12%beat | $659.9MSEC filing | +23.7%from $533.3M |
| Jun 30, 2025Reported Jul 21, 2025 | $3.10est. $3.00 | +3.33%beat | $603.3MSEC filing | +14.2%from $528.1M |
| Mar 31, 2025Reported Apr 21, 2025 | $3.67est. $3.07 | +19.54%beat | $558.6MSEC filing | +9.3%from $511.0M |
| Dec 31, 2024Reported Feb 10, 2025 | $3.68est. $3.12 | +18.12%beat | $536.6MAlpha Vantage | +7.7%from $498.4M |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $708.5M | $706.6M | $707.3M | $716.0M |
| Cost of what it sold | $503.1M | $510.3M | $505.7M | $492.1M |
| Gross profit | $205.3M | $196.3M | $201.6M | $223.9M |
| What it spent | ||||
| Sales and admin | $44.9M | $47.9M | $48.1M | $51.8M |
| Other operating costs | $7.1M | $6.9M | $6.7M | $6.6M |
| Total operating expenses | $52.0M | $54.8M | $54.8M | $58.3M |
| What was left | ||||
| Operating profit | $153.3M | $141.5M | $146.8M | $165.5M |
| Profit before tax | $156.8M | $147.6M | $151.7M | $170.9M |
| Tax | $21.7M | $23.7M | $30.3M | $33.4M |
| Net profit | $135.1M | $123.9M | $121.4M | $137.5M |
| EBITDA | $164.0M | $154.5M | $147.6M | $177.5M |
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage leans bearish
Is Medpace Holdings (MEDP) Fully Valued On Record Q3 Awards And Pipeline Growth?
NeutralNov 8Earnings Beat Might Change The Case For Investing In Medpace Stock (MEDP)
Leans bullishNov 7Medpace Holdings Inc (01P.DE) stock price, news, quote and history
NeutralNov 6Form 4 Medpace Holdings Inc: Stephen P. Ewald (General Counsel & Corp. Secy.) For: 29 October
NeutralNov 3At $690 a share, Medpace (MEDP) counsel Stephen P. Ewald sells 1,245 shares.
Leans bearishNov 3Form 4 Medpace Holdings Inc: Stephen P. Ewald (General Counsel & Corp. Secy.) For: 29 October
NeutralNov 3Medpace Holdings general counsel sells $859,050 in common stock
Leans bearishNov 3Form 4 Medpace Holdings Inc: Stephen P. Ewald (General Counsel & Corp. Secy.) For: 29 October
NeutralNov 333 macro signals shaping MEDP right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results
